Logo image of AMRC

AMERESCO INC-CL A (AMRC) Stock Fundamental Analysis

USA - NYSE:AMRC - US02361E1082 - Common Stock

27.39 USD
+0.06 (+0.22%)
Last: 9/12/2025, 8:04:00 PM
27.4 USD
+0.01 (+0.04%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

3

Taking everything into account, AMRC scores 3 out of 10 in our fundamental rating. AMRC was compared to 52 industry peers in the Construction & Engineering industry. Both the profitability and financial health of AMRC have multiple concerns. AMRC is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

AMRC had positive earnings in the past year.
AMRC had a negative operating cash flow in the past year.
In the past 5 years AMRC has always been profitable.
AMRC had negative operating cash flow in 4 of the past 5 years.
AMRC Yearly Net Income VS EBIT VS OCF VS FCFAMRC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200M -400M -600M

1.2 Ratios

AMRC has a Return On Assets of 1.44%. This is in the lower half of the industry: AMRC underperforms 61.54% of its industry peers.
With a Return On Equity value of 5.99%, AMRC perfoms like the industry average, outperforming 44.23% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 2.16%, AMRC is doing worse than 65.38% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for AMRC is significantly below the industry average of 17.22%.
Industry RankSector Rank
ROA 1.44%
ROE 5.99%
ROIC 2.16%
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
AMRC Yearly ROA, ROE, ROICAMRC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

AMRC's Profit Margin of 3.33% is in line compared to the rest of the industry. AMRC outperforms 51.92% of its industry peers.
In the last couple of years the Profit Margin of AMRC has declined.
Looking at the Operating Margin, with a value of 5.11%, AMRC is in line with its industry, outperforming 48.08% of the companies in the same industry.
In the last couple of years the Operating Margin of AMRC has declined.
Looking at the Gross Margin, with a value of 14.48%, AMRC is in line with its industry, outperforming 42.31% of the companies in the same industry.
In the last couple of years the Gross Margin of AMRC has declined.
Industry RankSector Rank
OM 5.11%
PM (TTM) 3.33%
GM 14.48%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
AMRC Yearly Profit, Operating, Gross MarginsAMRC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), AMRC is destroying value.
Compared to 1 year ago, AMRC has more shares outstanding
Compared to 5 years ago, AMRC has more shares outstanding
AMRC has a better debt/assets ratio than last year.
AMRC Yearly Shares OutstandingAMRC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AMRC Yearly Total Debt VS Total AssetsAMRC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AMRC has an Altman-Z score of 1.11. This is a bad value and indicates that AMRC is not financially healthy and even has some risk of bankruptcy.
AMRC has a worse Altman-Z score (1.11) than 73.08% of its industry peers.
A Debt/Equity ratio of 1.61 is on the high side and indicates that AMRC has dependencies on debt financing.
The Debt to Equity ratio of AMRC (1.61) is worse than 73.08% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACC0.21
WACC10.23%
AMRC Yearly LT Debt VS Equity VS FCFAMRC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

2.3 Liquidity

AMRC has a Current Ratio of 1.56. This is a normal value and indicates that AMRC is financially healthy and should not expect problems in meeting its short term obligations.
AMRC has a Current ratio of 1.56. This is in the better half of the industry: AMRC outperforms 71.15% of its industry peers.
A Quick Ratio of 1.54 indicates that AMRC should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.54, AMRC is in the better half of the industry, outperforming 76.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.54
AMRC Yearly Current Assets VS Current LiabilitesAMRC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 8.33% over the past year.
The Earnings Per Share has been growing slightly by 3.47% on average over the past years.
AMRC shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.86%.
Measured over the past years, AMRC shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)8.33%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%166.67%
Revenue 1Y (TTM)22.86%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%7.83%

3.2 Future

AMRC is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 16.97% yearly.
Based on estimates for the next years, AMRC will show a quite strong growth in Revenue. The Revenue will grow by 8.41% on average per year.
EPS Next Y-24.22%
EPS Next 2Y6.72%
EPS Next 3Y19.72%
EPS Next 5Y16.97%
Revenue Next Year8.47%
Revenue Next 2Y8.91%
Revenue Next 3Y9.97%
Revenue Next 5Y8.41%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AMRC Yearly Revenue VS EstimatesAMRC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
AMRC Yearly EPS VS EstimatesAMRC Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.41, the valuation of AMRC can be described as rather expensive.
76.92% of the companies in the same industry are more expensive than AMRC, based on the Price/Earnings ratio.
AMRC is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 23.58, AMRC is valued on the expensive side.
AMRC's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AMRC is cheaper than 63.46% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.73. AMRC is around the same levels.
Industry RankSector Rank
PE 23.41
Fwd PE 23.58
AMRC Price Earnings VS Forward Price EarningsAMRC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AMRC is valued a bit cheaper than 65.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.39
AMRC Per share dataAMRC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

A more expensive valuation may be justified as AMRC's earnings are expected to grow with 19.72% in the coming years.
PEG (NY)N/A
PEG (5Y)6.74
EPS Next 2Y6.72%
EPS Next 3Y19.72%

0

5. Dividend

5.1 Amount

AMRC does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AMERESCO INC-CL A

NYSE:AMRC (9/12/2025, 8:04:00 PM)

After market: 27.4 +0.01 (+0.04%)

27.39

+0.06 (+0.22%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryConstruction & Engineering
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-05 2025-11-05/amc
Inst Owners96.9%
Inst Owner Change7.24%
Ins Owners7.71%
Ins Owner Change2.33%
Market Cap1.44B
Analysts76.47
Price Target31.62 (15.44%)
Short Float %8.3%
Short Ratio3.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)609.63%
Min EPS beat(2)64.35%
Max EPS beat(2)1154.9%
EPS beat(4)2
Avg EPS beat(4)294.8%
Min EPS beat(4)-31.77%
Max EPS beat(4)1154.9%
EPS beat(8)4
Avg EPS beat(8)141.87%
EPS beat(12)5
Avg EPS beat(12)92.1%
EPS beat(16)9
Avg EPS beat(16)74.97%
Revenue beat(2)2
Avg Revenue beat(2)12.17%
Min Revenue beat(2)11.49%
Max Revenue beat(2)12.84%
Revenue beat(4)3
Avg Revenue beat(4)6.23%
Min Revenue beat(4)-0.4%
Max Revenue beat(4)12.84%
Revenue beat(8)6
Avg Revenue beat(8)5.83%
Revenue beat(12)9
Avg Revenue beat(12)5.12%
Revenue beat(16)11
Avg Revenue beat(16)4.39%
PT rev (1m)15.64%
PT rev (3m)32.9%
EPS NQ rev (1m)-47.34%
EPS NQ rev (3m)-61.82%
EPS NY rev (1m)-1.33%
EPS NY rev (3m)-0.73%
Revenue NQ rev (1m)-2.73%
Revenue NQ rev (3m)-3.37%
Revenue NY rev (1m)1.25%
Revenue NY rev (3m)1.35%
Valuation
Industry RankSector Rank
PE 23.41
Fwd PE 23.58
P/S 0.78
P/FCF N/A
P/OCF N/A
P/B 1.4
P/tB 1.51
EV/EBITDA 16.39
EPS(TTM)1.17
EY4.27%
EPS(NY)1.16
Fwd EY4.24%
FCF(TTM)-8.22
FCFYN/A
OCF(TTM)-0.22
OCFYN/A
SpS35.27
BVpS19.63
TBVpS18.15
PEG (NY)N/A
PEG (5Y)6.74
Profitability
Industry RankSector Rank
ROA 1.44%
ROE 5.99%
ROCE 2.74%
ROIC 2.16%
ROICexc 2.21%
ROICexgc 2.27%
OM 5.11%
PM (TTM) 3.33%
GM 14.48%
FCFM N/A
ROA(3y)2.11%
ROA(5y)2.51%
ROE(3y)8%
ROE(5y)8.99%
ROIC(3y)3.15%
ROIC(5y)3.6%
ROICexc(3y)3.29%
ROICexc(5y)3.76%
ROICexgc(3y)3.41%
ROICexgc(5y)3.91%
ROCE(3y)3.99%
ROCE(5y)4.56%
ROICexcg growth 3Y-23.67%
ROICexcg growth 5Y-13.36%
ROICexc growth 3Y-23.08%
ROICexc growth 5Y-12.71%
OM growth 3Y-16.55%
OM growth 5Y-4.81%
PM growth 3Y-17.89%
PM growth 5Y-8.97%
GM growth 3Y-8.6%
GM growth 5Y-5.69%
F-Score5
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 1.61
Debt/FCF N/A
Debt/EBITDA 8.56
Cap/Depr 425.09%
Cap/Sales 22.67%
Interest Coverage 0.88
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.54
Altman-Z 1.11
F-Score5
WACC10.23%
ROIC/WACC0.21
Cap/Depr(3y)645.79%
Cap/Depr(5y)553.31%
Cap/Sales(3y)27.71%
Cap/Sales(5y)23.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.33%
EPS 3Y-12.06%
EPS 5Y3.47%
EPS Q2Q%166.67%
EPS Next Y-24.22%
EPS Next 2Y6.72%
EPS Next 3Y19.72%
EPS Next 5Y16.97%
Revenue 1Y (TTM)22.86%
Revenue growth 3Y13.34%
Revenue growth 5Y15.34%
Sales Q2Q%7.83%
Revenue Next Year8.47%
Revenue Next 2Y8.91%
Revenue Next 3Y9.97%
Revenue Next 5Y8.41%
EBIT growth 1Y9.47%
EBIT growth 3Y-5.42%
EBIT growth 5Y9.79%
EBIT Next Year91.21%
EBIT Next 3Y38.95%
EBIT Next 5Y27.64%
FCF growth 1Y18.27%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y81.79%
OCF growth 3YN/A
OCF growth 5YN/A